Public Market Secondary Issues
Evonile Pharma approves Rs.900-Cr rights issue
Mumbai-based Evonile Pharma (formerly known as Novartis India) would raise INR 900 crore through a rights issue. The transaction involves the issuance of partly paid-up equity shares with a face value of INR 5 each to eligible equity shareholders.Evonile Pharma is focused primarily on commercialising and marketing medicines across major…
Read the full story →